2,2-Dimethylbutyrate (DMB) is a potential treatment for thalassemia and hemoglobinopathies.
参考文献
Yeh, K., et al.: J. Pharmacokinet. Biopharm., 6, 79 (1978), Cunningham, M., et al.: Blood, 104, 34 (2004), Rund, D., et al.: N. Engl. J. Med., 353, 1135 (2005),